ADL

Ciron has carved a niche for itself in the sphere of operations of manufacturing Ampoules, Vials, Eye / Ear / Nasal drops, Lyophilized products and Lyophilized bulk. Manufactured in India, these niche products help make CIRON market-friendly in India and abroad.  Along with training of technical personnel, CIRON invests almost 40% of its Annual Profits in acquiring the latest machinery for its plant; ensuring a constant upgrade in the quality of its products, keeping them in line with the finest in technology.

Synokem Pharmaceuticals emanated from August 1983, under the Leadership of our Chairman - Mr. J.M.Arora. Mr. Abhinav Arora – Managing Director is leading the company under the able guidance of our Honble Chairman. The Company has flung its wings and has grown into a large business conglomerate as Manufacturers, Marketer, Exporter and Government Tenderer.

Post: Executive/ Officer/ Fresher (Quality Control), ADL, Executive (Production) , Executive (IPQA)

Torrent Pharma, the flagship company of Torrent Group, is ranked amongst the top pharma companies of India. It is a dominant player in the therapeutic areas of cardiovascular (CV) and central nervous system (CNS) and has achieved significant presence in gastro-intestinal, diabetology, anti-infective and pain management segments. Torrent Pharma has a strong international presence spanning over 70 countries with over 1200 product registrations.

CORONA Remedies Private Limited is the Fastest Growing Pharmaceutical organization is looking for capable and dynamic candidates for suitable positions of our EU GMP Standard compliant OSD (Oral Solid Dosage) Facility at Bhayla, Ahmedabad.

ADL Department

SUSHEN Medicamentos Pvt. Ltd. (SUSHEN), is a global company of end-to-end pharmaceutical services with focus on drug delivery research and product development. SUSHEN’s expertise and flexibility can bring a complex formulation project in to clinical and bioequivalence withsuperior quality, innovative solution. At SUSHEN, we provide complete turnkey solutions to the pharmaceutical industry, right from conceptualizing and designing a new plant to its construction and setting up of manufacturing facilities to its commissioning.

Rusan Pharma Ltd. is a fully integrated global pharmaceutical company specializing in the treatment of Addiction and Pain Management.  We offer a complete range of products for de-addiction and pain management in countries across the globe including Europe, UK, Russia, CIS, South Africa, Mauritius, Nepal and Myanmar. We are one of the largest suppliers of life saving drugs to various organizations such as NACO, UNODC, UNOPS, Global Fund and Ministries of health in various emerging markets.

Torrent Pharma, the flagship company of Torrent Group, is ranked amongst the top pharma companies of India. It is a dominant player in the therapeutic areas of cardiovascular (CV) and central nervous system (CNS) and has achieved significant presence in gastro-intestinal, diabetology, anti-infective and pain management segments. Torrent Pharma has a strong international presence spanning over 70 countries with over 1200 product registrations.

Lincoln Pharmaceuticals shares its presence with fellow foremost top notch excellence driven pharmaceutical producers, engaged in manufacturing and marketing several therapeutic molecules under WHO-GMP guidelines. What makes Lincoln stands apart is their commitment to deliver unsurpassed quality of innovative products for the betterment of human health. Our drugs are developed using best in class guidelines and all that at a very cost-effective rates.

Rusan Pharma Ltd. is a fully integrated global pharmaceutical company specializing in the treatment of Addiction and Pain Management.  We offer a complete range of products for de-addiction and pain management in countries across the globe including Europe, UK, Russia, CIS, South Africa, Mauritius, Nepal and Myanmar. We are one of the largest suppliers of life saving drugs to various organizations such as NACO, UNODC, UNOPS, Global Fund and Ministries of health in various emerging markets.